Huize pioneers DeepSeek integration in China's insurance sector, revolutionizing consumer-facing insurance services for the AI era

Stock Information for Navidea Biopharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Navidea Biopharmaceuticals Inc.

Huize Holding Limited Reports First Quarter 2025 Unaudited Financial Results
Huize Holding Limited to Report First Quarter 2025 Financial Results on June 6, 2025
Huize Holding Limited Files 2024 Annual Report on Form 20-F
Huize Holding Limited Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results
Huize Holding Limited to Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025
Huize Served Over 1.3 Million Families, Facilitating More Than 12 Million Insurance Policies in 2024
Huize Launches Customized Mid-Tier Medical Insurance Product "PrimeMed" in Partnership with CCIC and MSH CHINA
Huize Regains Compliance with Nasdaq Minimum Bid Price Requirement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.